Article
DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Oct 2009
Saintigny Pierre, El-Naggar Adel K, Papadimitrakopoulou Vali, Ren Hening, Fan You-Hong, Feng Lei, Lee J Jack, Kim Edward S, Hong Waun Ki, Lippman Scott M, Mao Li
Abstract excerpt
PURPOSE: The risk of malignant transformation of oral preneoplastic lesion (OPL) is difficult to assess. DeltaNp63 is an early oncoprotein associated with mucosal tumorigenesis. The purpose of this study was to assess DeltaNp63 expression in OPL and its role as a marker of oral cancer risk. EXPERIMENTAL DESIGN: DeltaNp63 expression was determined using immunohistochemistry in 152 OPL patients included in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
